• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠脉综合征伴血小板减少症行经皮冠状动脉介入治疗患者的基线治疗血小板反应性的长期影响。

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention.

机构信息

Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Kunming, Yunnan Province, China.

出版信息

J Int Med Res. 2022 Apr;50(4):3000605221081725. doi: 10.1177/03000605221081725.

DOI:10.1177/03000605221081725
PMID:35441555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9047852/
Abstract

OBJECTIVE

To analyse the association between on-treatment platelet reactivity (TPR) and long-term outcomes of patients with acute coronary syndrome (ACS) and thrombocytopenia (TP) in the real world.

METHODS

This prospective observational study enrolled patients with coronary artery disease (CAD) that underwent percutaneous coronary intervention (PCI). Patients with ACS and TP under dual antiplatelet therapy were selected for analysis. The 2- and 5-year clinical outcomes were evaluated among patients with high on-treatment platelet reactivity (HTPR), low on-treatment platelet reactivity (LTPR) and normal on-treatment platelet reactivity (NTPR), as tested by thromboelastogram at baseline.

RESULTS

A total of 10 724 patients with CAD that underwent PCI were identified. Of these, 474 patients with ACS and TP met the inclusion criteria: 124 (26.2%) with HTPR, 163 (34.4%) with LTPR and 187 (39.5%) with NTPR. The 5-year rates of all-cause death, major adverse cardiovascular and cerebrovascular events, cardiac death, myocardial infarction, revascularization, stroke and bleeding were not significantly different among the three groups. Multivariate Cox regression analysis demonstrated that patients with HTPR were not independently associated with any of the 5-year endpoints compared with patients with NTPR.

CONCLUSIONS

TPR at baseline was not independently associated with long-term outcomes in patients with ACS and TP that underwent PCI.

摘要

目的

分析在真实世界中,急性冠状动脉综合征(ACS)和血小板减少症(TP)患者的治疗中血小板反应性(TPR)与长期结局之间的关系。

方法

这项前瞻性观察性研究纳入了接受经皮冠状动脉介入治疗(PCI)的冠心病患者。选择接受双联抗血小板治疗的 ACS 和 TP 患者进行分析。通过基线血栓弹力图检测,评估高治疗中血小板反应性(HTPR)、低治疗中血小板反应性(LTPR)和正常治疗中血小板反应性(NTPR)患者的 2 年和 5 年临床结局。

结果

共纳入 10724 例接受 PCI 的 CAD 患者,其中 474 例 ACS 和 TP 患者符合纳入标准:HTPR 患者 124 例(26.2%),LTPR 患者 163 例(34.4%),NTPR 患者 187 例(39.5%)。三组患者的全因死亡、主要心血管和脑血管不良事件、心脏死亡、心肌梗死、血运重建、卒中和出血的 5 年发生率无显著差异。多变量 Cox 回归分析表明,与 NTPR 患者相比,HTPR 患者与任何 5 年终点均无独立相关性。

结论

PCI 治疗后的 ACS 和 TP 患者,基线 TPR 与长期结局无独立相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b5/9047852/6b689b2cb770/10.1177_03000605221081725-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b5/9047852/39cc89a31eca/10.1177_03000605221081725-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b5/9047852/6b689b2cb770/10.1177_03000605221081725-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b5/9047852/39cc89a31eca/10.1177_03000605221081725-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98b5/9047852/6b689b2cb770/10.1177_03000605221081725-fig2.jpg

相似文献

1
Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention.急性冠脉综合征伴血小板减少症行经皮冠状动脉介入治疗患者的基线治疗血小板反应性的长期影响。
J Int Med Res. 2022 Apr;50(4):3000605221081725. doi: 10.1177/03000605221081725.
2
Inflammation modifies the platelet reactivity among thrombocytopenia patients undergoing percutaneous coronary intervention.炎症可改变血小板减少症行经皮冠状动脉介入治疗患者的血小板反应性。
Platelets. 2024 Dec;35(1):2327835. doi: 10.1080/09537104.2024.2327835. Epub 2024 Apr 24.
3
Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗的急性冠状动脉综合征与稳定型冠状动脉疾病患者的高治疗反应血小板活性的预后差异影响。
Am Heart J. 2013 Jan;165(1):34-42.e1. doi: 10.1016/j.ahj.2012.10.013. Epub 2012 Nov 17.
4
Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention.基线血小板减少症对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者缺血性结局的影响。
Can J Cardiol. 2016 Feb;32(2):226-33. doi: 10.1016/j.cjca.2015.05.020. Epub 2015 Jun 5.
5
Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的稳定型冠状动脉疾病患者中,血小板对氯吡格雷反应的变异性与不良心血管事件无关。
Eur J Clin Pharmacol. 2017 Sep;73(9):1085-1094. doi: 10.1007/s00228-017-2271-x. Epub 2017 Jun 6.
6
Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.急性冠状动脉综合征经皮冠状动脉介入治疗患者负荷剂量替格瑞洛后用 VASP 检测血小板反应性。
Thromb Res. 2013 Jul;132(1):e15-8. doi: 10.1016/j.thromres.2013.04.030. Epub 2013 May 30.
7
Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation.双联抗血小板治疗后血小板高反应性与日本经皮冠状动脉介入治疗患者缺血事件的关系。
J Atheroscler Thromb. 2020 Jan 1;27(1):13-24. doi: 10.5551/jat.48934. Epub 2019 May 14.
8
Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.通过VerifyNow P2Y12检测评估的P2Y12反应单位与血小板抑制百分比的组合,是接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者长期临床结局的有用预测指标。
Thromb Res. 2016 Mar;139:114-20. doi: 10.1016/j.thromres.2016.01.020. Epub 2016 Jan 27.
9
[Effect of platelet reactivity on clinical events in patients using bivalirudin in selective percutaneous coronary intervention].[血小板反应性对接受比伐卢定选择性经皮冠状动脉介入治疗患者临床事件的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Aug 24;49(8):783-789. doi: 10.3760/cma.j.cn112148-20210106-00014.
10
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.一项关于接受经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征(ACS)患者血小板功能引导下抗血小板治疗降阶梯的随机试验。急性冠状动脉综合征慢性抗血小板治疗中血小板抑制反应性测试(TROPICAL-ACS)试验的原理与设计。
Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.

引用本文的文献

1
Anti-Inflammatory and Antiplatelet Interactions on PAF and ADP Pathways of NSAIDs, Analgesic and Antihypertensive Drugs for Cardioprotection-In Vitro Assessment in Human Platelets.非甾体抗炎药、镇痛药及抗高血压药对血小板活化因子(PAF)和二磷酸腺苷(ADP)途径的抗炎及抗血小板相互作用——人体血小板的体外评估用于心脏保护
Medicina (Kaunas). 2025 Aug 4;61(8):1413. doi: 10.3390/medicina61081413.
2
The relationship between ABO blood types and clopidogrel-related low on-treatment platelet reactivity in patients with coronary artery diseases and type 2 diabetes mellitus: a secondary analysis of a prospective cohort study.冠心病合并2型糖尿病患者ABO血型与氯吡格雷相关的治疗中血小板低反应性的关系:一项前瞻性队列研究的二次分析
Diabetol Metab Syndr. 2025 May 13;17(1):151. doi: 10.1186/s13098-025-01716-6.
3

本文引用的文献

1
Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.基线血小板减少对择期经皮冠状动脉介入治疗患者长期预后的影响:连续 9897 例患者的分析。
Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):764-771. doi: 10.1002/ccd.28030. Epub 2018 Dec 26.
2
Association of thrombocytopenia with in-hospital outcome in patients with acute ST-segment elevated myocardial infarction.血小板减少与急性 ST 段抬高型心肌梗死患者住院结局的关联。
Platelets. 2019;30(7):844-853. doi: 10.1080/09537104.2018.1529298. Epub 2018 Oct 22.
3
Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study.伴有血小板减少症的非心源性缺血性卒中抗血小板治疗的安全性:CASE II 研究。
J Am Heart Assoc. 2024 Aug 20;13(16):e032327. doi: 10.1161/JAHA.123.032327. Epub 2024 Aug 9.
4
Safety of early antiplatelet therapy for non-cardioembolic mild stroke patients with thrombocytopenia.非心源性轻度卒中伴血小板减少症患者早期抗血小板治疗的安全性。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Apr 25;53(2):175-183. doi: 10.3724/zdxbyxb-2023-0423.
Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention.
平均血小板体积对接受择期经皮冠状动脉介入治疗的糖尿病合并稳定型冠状动脉疾病患者的两年预后价值。
Cardiol J. 2019;26(2):138-146. doi: 10.5603/CJ.a2018.0071. Epub 2018 Jul 16.
4
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的抗血小板治疗降级指导(TROPICAL-ACS):一项随机、开放标签、多中心试验。
Lancet. 2017 Oct 14;390(10104):1747-1757. doi: 10.1016/S0140-6736(17)32155-4. Epub 2017 Aug 28.
5
Evaluation of platelet function in thrombocytopenia.血小板减少症中血小板功能的评估。
Platelets. 2018 May;29(3):270-276. doi: 10.1080/09537104.2017.1296566. Epub 2017 Apr 14.
6
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.血小板功能监测以调整急性冠状动脉综合征支架置入老年患者的抗血小板治疗(南极洲研究):一项开放标签、盲终点、随机对照优势试验
Lancet. 2016 Oct 22;388(10055):2015-2022. doi: 10.1016/S0140-6736(16)31323-X. Epub 2016 Aug 28.
7
Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention.基线血小板减少症对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者缺血性结局的影响。
Can J Cardiol. 2016 Feb;32(2):226-33. doi: 10.1016/j.cjca.2015.05.020. Epub 2015 Jun 5.
8
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.血小板功能测试,独立于血小板计数,与免疫性血小板减少性紫癜的出血严重程度相关。
Blood. 2015 Aug 13;126(7):873-9. doi: 10.1182/blood-2015-02-628461. Epub 2015 Jul 2.
9
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.抗血小板药物治疗后反应性血小板检测用于缺血和出血事件的共识与更新:ADP 相关性。
J Am Coll Cardiol. 2013 Dec 17;62(24):2261-73. doi: 10.1016/j.jacc.2013.07.101. Epub 2013 Sep 27.
10
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.2013年欧洲心脏病学会稳定型冠状动脉疾病管理指南:欧洲心脏病学会稳定型冠状动脉疾病管理特别工作组
Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 10.1093/eurheartj/eht296. Epub 2013 Aug 30.